From: The association between cognitive impairment and breast and colorectal cancer screening utilization
Female (N = 12,615) | ||
---|---|---|
Variables | Adjusted OR (95% CI) | p-value |
Cognitive impairment | ||
Mild vs. No impairment | 0.85 (0.74, 0.97) | = 0.015 |
Severe vs. No impairment | 0.54 (0.38, 0.76) | < 0.001 |
Age | ||
55–59 vs. 50–54 | 1.11 (0.94, 1.30) | = 0.220 |
60–64 vs. 50–54 | 1.11 (0.94, 1.30) | = 0.209 |
65–69 vs. 50–54 | 1.20 (1.02, 1.41) | = 0.031 |
70–74 vs. 50–54 | 1.02 (0.86, 1.22) | = 0.804 |
Race-ethnicitya | ||
NHB vs. NHW | 1.38 (1.16, 1.66) | < 0.001 |
NHO vs. NHW | 0.84 (0.69, 1.03) | = 0.097 |
Hispanic vs. NHW | 1.51 (1.25, 1.82) | < 0.001 |
Educationb | ||
> HS vs < = HS | 1.47 (1.32, 1.63) | < 0.001 |
Marital | ||
Live with spouse vs. Otherc | 1.51 (1.36, 1.68) | < 0.001 |
Single vs. Other | 0.94 (0.78,1.12) | = 0.481 |
Insurance coverage | ||
Insured vs. Uninsured | 4.22 (3.46, 5.16) | < 0.001 |
Cancer diagnosed | ||
Yes vs. No | 1.18 (1.03, 1.37) | = 0.021 |
Chronic disease scored | 1.07 (1.04, 1.12) | < 0.001 |